Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Profit After Tax: 2012-2024

Historic Profit After Tax for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to $159.5 million.

  • Amphastar Pharmaceuticals' Profit After Tax fell 57.09% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.6 million, marking a year-over-year decrease of 29.22%. This contributed to the annual value of $159.5 million for FY2024, which is 15.98% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Profit After Tax of $159.5 million as of FY2024, which was up 15.98% from $137.5 million recorded in FY2023.
  • Amphastar Pharmaceuticals' 5-year Profit After Tax high stood at $159.5 million for FY2024, and its period low was $1.4 million during FY2020.
  • In the last 3 years, Amphastar Pharmaceuticals' Profit After Tax had a median value of $137.5 million in 2023 and averaged $129.5 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Profit After Tax crashed by 97.13% in 2020 and then surged by 4,411.83% in 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' Profit After Tax (Yearly) stood at $1.4 million in 2020, then skyrocketed by 4,411.83% to $63.3 million in 2021, then skyrocketed by 44.37% to $91.4 million in 2022, then surged by 50.51% to $137.5 million in 2023, then increased by 15.98% to $159.5 million in 2024.